We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Setback For Mylan, Judge Upholds Levaquin Patent

Law360 (January 2, 2005, 12:00 AM EST) -- A federal judge has barred Mylan Laboratories Inc. from making a generic version of the antibiotic Levaquin until at least December 2010.

Last week, U.S. District Judge Irene M. Keeley prohibited Mylan from making or selling levofloxacin tablets, a generic form of Levaquin.

The drug is used to treat a variety of conditions, including bronchitis, sinusitis and urinary tract infections.

Ortho-McNeil Pharmaceutical Inc., a Johnson & Johnson company that sells Levaquin in the U.S., and Japanese patent-owner Daiichi Pharmaceutical Co. had filed their first lawsuit in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.